Ann Zovein

Ann Zovein has extensive experience in the biopharmaceutical and academic sectors, holding significant leadership roles such as Senior Vice President and Head of Translational Science at Angitia Biopharmaceuticals, and Vice President of Clinical Development at Amgen. Zovein's background includes key positions such as Molecular Genetics Director and Medical Director in Translational Medicine at Amgen, as well as Fellow at Westwood Ventures. An academic career includes tenured faculty and Principal Investigator roles at the University of California, San Francisco, along with service as a member of the Cellular, Tissue, and Gene Therapies Advisory Committee at the FDA. Zovein holds an MBA from UCLA Anderson School of Management and an M.D. from Boston University School of Medicine.